Evogene Evogene
Toggle navigation
  • Company
  • AI Tech-Engines
    • CPB Platform
  • Licensing & Collaboration
  • ESG
    • Environmental
    • Social
    • Governance
  • News & Events
  • Investors
  • Careers
  • Contact

News & Events

  • Press releases
  • In the media

Recent press releases

Evogene Schedules First Quarter 2025 Financial Results Release

May 8, 2025
Read full press release

ICL to Acquire the Activity of Evogene’s subsidiary, Lavie Bio

April 21, 2025
Read full press release

Evogene Reports Fourth Quarter and Full Year 2024 Financial Results

March 6, 2025
Read full press release
All Press releases

Upcoming events

Biomed Israel 2025

May 20, 2025
All events


Recently in the media

Discover Pharma – EXCLUSIVE interview: How foundation models are redefining small molecule drug discovery

May 8, 2025
Read article

Google Cloud – Evogene: Empowering innovation for life science products, with Google Cloud

May 5, 2025
Read article

BioSpace – Opinion: AI Enables Companies to Break From the Herd in Drug Development

April 7, 2025
Read article

Fierce Biotech – Google Cloud ‘can’t wait to see what’s next’ as Servier extends AI drug R&D pact

January 16, 2025
Read article

Vegconomist: Finally Foods Secures Funds for AI-Driven Plant Molecular Tech to Produce Casein for Cheese

April 9, 2024
Read article
Evogene
  • Technology
  • AI Tech-Engines
    • MicroBoost AI
    • ChemPass AI
    • GeneRator AI
  • Press
    • Press releases
    • In the media
    • Webcast
  • Investor Relations
  • About Evogene

Contact us

13 Gad Feinstein st.,
Park Rehovot,
Rehovot 7638517, Israel

Tel: 972-8-9311900
Fax: 972-8-9466724
E-mail: info@evogene.com

Facebook icon Linkedin icon

Copyright © 2024 Evogene Ltd.
All Rights Reserved.



CONTACT US

    INVESTOR EMAIL ALERTS

    Sign Up for Investor Relations Email Alerts






      Privacy Policy   Terms of Use   Accessibility Statement

      Designed and built by Studio Praktik